维普中文期刊产品整合服务
66篇 您的检索式:作者名="ZHAO MW"
    题名 作者 年代 出处 被引量
1Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue,and its possible role in tumor immunity显示文摘AIM:To investigate the expression of 4-1BB molecule in hepatocellular carcinoma (HCC) and its adjacent tissues.METHODS:Reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the gene expression of 4-1BB in hepatocarcinoma and its adjacent tissues,and peripheral blood mononuclear cells (PBMCs) from both HCC and health control groups.Flow cytometry was used to analyse the phenotypes of T cell subsets from the blood of HCC patients and healthy volunteers,and further to determine whether 4-1BB molecules were also expressed on the surface of CD4+ and CD8+ T cells. The localization of 4-1BB proteins on tumor infiltrating T cells was determined by direct immunofluorescence cytochemical staining and detected by confocal microscopy.RESULTS:4-1BB mRNA, which was not detectable in normal liver,was found in 19 liver tissues adjacent to tumor edge(<1.0cm).Low expression of 4-1BB mRNA was shown in 8 tumor tissues and 6 liver tissues located within 1 to 5cm away from tumor edge. In PBMCs, 4-1BB mRNA was almost not detected. Percentage of CD4^+, CD8^+ and CD3^+/CD25^+ T cells, as well as ratio of CD4 to CD8 revealed no difference between groups (P>0.05,respectively),while a significant lower percentage of CD3^+ T cell was found in HCC group as compared to healthy control group (P<0.05).However, 4-1BB molecules were almost not found on the surface of CD4+ and CD8+ T cells in HCC and healthy control group.Double-staining of 4-1BB^+/CD4^+ and 4-1BB^+/CD8^+ immunofluorescence on tumor infiltrating T cells was detected in 13 liver tissues adjacent to tumor edge (<1.0cm) by confocal microscopy.CONCLUSION: Although HCC may escape from immune attack by weak immunogenicity or downregulated expression of MHC-1 molecules on the tumor cell surface,tumor infiltrating T cells can be activated via other costimulatory signal pathways to exert a limited antitumor effect on local microenvironment. The present study also implicates that modulating 4-1BB/4-1BBL costimulatory pathway may be an effective immunotherapy strategy to augment the host response.Wan, YL Zheng, SS Zhao, ZC Li, MW Jia, CK Zhang, H 2004World Journal of Gastroenterology2004,10,2:6
2A comparison of renalrelated adverse drug reactions between rofeeoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database显示文摘Zhao S Z Reynolds MW Lejkowith J 2001Clin Ther2001,23,9:1
3Studies on chacacteristics of AmpC- type beta-lactamases of Enterobacter cloacae显示文摘Zhang YL Li JT Zhao MW 2000Chin J Antibiot2000,20,6:1
4Impact of clinical trial design and execution - related factors on incidence of thromboembolic events in cancer patients : A systematic review and meta - analysis 显示文摘Reynolds MW Shibata A Zhao S 2008Curr Med Res Opin2008,24,2:1
5CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme显示文摘Zhao XQ Zhang MW Wang F 0,,05:1
6Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dosage of verteporfin 显示文摘Zhao MW Zhou P Xiao HX 2009Retina2009,29,8:1
7A distinct integrin -midiated phagocytic pathway for extracellular matrix remodelling by RPE cells显示文摘Zhao MW Jin ML He SK 1999Invest Ophthalmol Vis Sci1999,40,11:1
8Association of plasma total and high-molecular-weight adiponeetin with risk of eoloreetal cancer: an observational study in Chinese male显示文摘Chen MW Ye S Zhao LL 2012Med Oneol2012,29,5:1
9Thesequence and de novo assembly of the giant panda genome显示文摘LI R FAN W TIAN G ZHU H HE L CAI J HUANG Q CAIQ LI B BAI Y ZHANG Z ZHANG Y WANG W LI J WEI F LI H JIAN M LI J ZHANG Z NIELSEN R LI D GU W YANG Z XUAN Z RYDER OA LEUNG FC ZHOU Y CAO J SUN X FU Y FANG X GUO X WANG B HOU R SHEN F MU B NI P LIN R QIAN W WANG G YU C NIE W WANGJ WU Z LIANG H MIN J WU Q CHENG S RUAN J WANGM SHI Z WEN M LIU B REN X ZHENG H DONG D COOKK SHAN G ZHANG H KOSIOL C XIE X LU Z ZHENG H LI Y STEINER CC LAM TT LIN S ZHANG Q LI G TIAN J GONG T LIU H ZHANG D FANG L YE C ZHANG J HU W XU A REN Y ZHANG G BRUFORD MW LI Q MA L GUOY AN N HU Y ZHENG Y SHI Y LI Z LIU Q CHEN Y ZHAO J QU N ZHAO S TIAN F WANG X WANG H XU L LIU X VINAR T WANG Y LAM TW YIU SM LIU S ZHANGH LI D HUANG Y WANG X YANG G JIANG Z WANG J QIN N LI L LI J BOLUND L KRISTIANSEN K WONG GK OLSON M ZHANG X LI S YANG H WANG J WANG J 2010Na-ture2010,463,:1
10Photodynamic therapy for acute central serous cho~ioreti- nopathy: the safe effective lowest dose of vertepofin显示文摘ZHAO MW ZHAO P XlAO HX LV YS LI CA LIU GD 2009Retina2009,29,8:1
11Manual Small Incision 20-Gauge Pars Plana Vitrectomy显示文摘Zhao MW Zhou P Li XX 0,,:1
12Association of gene polymorphisms of TNF-Q and IL-8 with COPD in Han nationality in beijing显示文摘Jiang L He B Zhao MW 2005Chin Med J2005,118,17:1
13Photodynamie therapy for acute central serous chorioretinopathy:the safe effective lowest dose of verteporfin 显示文摘Zhao MW Zhou P Xiao HX 2009Retina2009,29,:1
14Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium显示文摘Zhao ZQ Sato H Williams MW 1996Am J Physiol1996,71,:1
15Immunostimulatory and anti- tumor activity of a water-soluble polysaccharide from PheUi- nus baumii mycelia 显示文摘Xue Q Sun J Zhao MW 2011World Journal of Microbiology & Biotechnology2011,27,:1
16Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin 显示文摘Zhao MW Zhou P Xiao HX 2009Retina2009,29,:1
17Manual small incision 20-gauge pars plana vitrectomy显示文摘Zhao MW Zhou P Cui X 0,,:1
18Manual small incision 20-Gauge parsplana vitrectomy显示文摘Zhao MW Zhou P Cui X 2009Retina2009,29,9:1
19CRP Enhances Soluble LOX-1 Release from Macrophages by Activating TNF-alpha Converting Enzyme 显示文摘Zhao XQ Zhang MW Wang F 2011Journal of Lipid Research2011,52,5:1
20Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfi n~显示文摘Zhao MW Zhou P Xiao HX 2009Retina2009,29,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费